Showing results (151-160 of 315) with videos related to

Sort By:
Pageof 32
Pathophysiology of Haemostasis and Thrombosis|September 6, 2002
Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarctionApar Kishor Ganti, Anil Potti, Radha Yegnanarayan
Pathophysiology of Haemostasis and Thrombosis|September 6, 2002
Effects of aspirin and clopidogrel versus oral anticoagulation on platelet function and on coagulation in patients with nonvalvular atrial fibrillation (CLAFIB)Iris Müller, Steffen Massberg, Wolfgang Zierhut, et al.
Pathophysiology of Haemostasis and Thrombosis|September 6, 2002
The 2000 United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) inhibitor guidelinesC R M Hay,
Pathophysiology of Haemostasis and Thrombosis|September 6, 2002
Economic impact of treating inhibitor patientsLoretto Lacey
Pathophysiology of Haemostasis and Thrombosis|May 22, 2003
Intensity of long-term treatment with warfarin is influenced by seasonal variationsBarbara Salobir, Miso Sabovic, Polona Peternel
Pathophysiology of Haemostasis and Thrombosis|May 22, 2003
Bound thrombin from crushed clots is composed of alpha-thrombin and the N-terminal regions of alpha- and gamma-chains of fibrinogenKiyohiko Kinjoh, Mariko Nakamura, Zeng Gang, et al.
Pathophysiology of Haemostasis and Thrombosis|June 18, 2003
Current developments in antithrombotic therapy: the role of antithrombin agentsH K Breddin
Pathophysiology of Haemostasis and Thrombosis|June 18, 2003
An overview of the direct thrombin inhibitor argatrobanJeanine M Walenga
Pathophysiology of Haemostasis and Thrombosis|August 18, 2010
New insight into the mechanism of Lonomia obliqua envenoming: toxin involvement and molecular approachM P Alvarez Flores, M Zannin, A M Chudzinski-Tavassi
Pageof 32